Your browser doesn't support javascript.
loading
Proinflammatory cytokines suppress nonsense-mediated RNA decay to impair regulated transcript isoform processing in pancreatic ß cells.
Ghiasi, Seyed M; Marchetti, Piero; Piemonti, Lorenzo; Nielsen, Jens H; Porse, Bo T; Mandrup-Poulsen, Thomas; Rutter, Guy A.
Afiliação
  • Ghiasi SM; Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, United Kingdom.
  • Marchetti P; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Piemonti L; Development and Aging Program, and Human Genetics Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States.
  • Nielsen JH; Department of Clinical and Experimental Medicine, Islet Cell Laboratory, University of Pisa, Pisa, Italy.
  • Porse BT; Diabetes Research Institute, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) Ospedale San Raffaele, Milano, Italy.
  • Mandrup-Poulsen T; Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Rutter GA; Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark.
Front Endocrinol (Lausanne) ; 15: 1359147, 2024.
Article em En | MEDLINE | ID: mdl-38586449
ABSTRACT

Introduction:

Proinflammatory cytokines are implicated in pancreatic ß cell failure in type 1 and type 2 diabetes and are known to stimulate alternative RNA splicing and the expression of nonsense-mediated RNA decay (NMD) components. Here, we investigate whether cytokines regulate NMD activity and identify transcript isoforms targeted in ß cells.

Methods:

A luciferase-based NMD reporter transiently expressed in rat INS1(832/13), human-derived EndoC-ßH3, or dispersed human islet cells is used to examine the effect of proinflammatory cytokines (Cyt) on NMD activity. The gain- or loss-of-function of two key NMD components, UPF3B and UPF2, is used to reveal the effect of cytokines on cell viability and function. RNA-sequencing and siRNA-mediated silencing are deployed using standard techniques.

Results:

Cyt attenuate NMD activity in insulin-producing cell lines and primary human ß cells. These effects are found to involve ER stress and are associated with the downregulation of UPF3B. Increases or decreases in NMD activity achieved by UPF3B overexpression (OE) or UPF2 silencing raise or lower Cyt-induced cell death, respectively, in EndoC-ßH3 cells and are associated with decreased or increased insulin content, respectively. No effects of these manipulations are observed on glucose-stimulated insulin secretion. Transcriptomic analysis reveals that Cyt increases alternative splicing (AS)-induced exon skipping in the transcript isoforms, and this is potentiated by UPF2 silencing. Gene enrichment analysis identifies transcripts regulated by UPF2 silencing whose proteins are localized and/or functional in the extracellular matrix (ECM), including the serine protease inhibitor SERPINA1/α-1-antitrypsin, whose silencing sensitizes ß-cells to Cyt cytotoxicity. Cytokines suppress NMD activity via UPR signaling, potentially serving as a protective response against Cyt-induced NMD component expression.

Conclusion:

Our findings highlight the central importance of RNA turnover in ß cell responses to inflammatory stress.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina / Insulinas Limite: Animals / Humans Idioma: En Revista: Front Endocrinol (Lausanne) / Front. endocrinol. (Lausanne) / Frontiers in endocrinology (Lausanne) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Células Secretoras de Insulina / Insulinas Limite: Animals / Humans Idioma: En Revista: Front Endocrinol (Lausanne) / Front. endocrinol. (Lausanne) / Frontiers in endocrinology (Lausanne) Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Reino Unido